Adverse events of concomitant use of immune checkpoint inhibitors and metformin or statin: an observational, retrospective disproportionality analysis
The observations delineated offer pivotal insights into the refinement of the co-administration strategy for ICIs with metformin or statins, attenuating the incidence of adverse side effects.
Authors
- Wei Wang (ORCID: https://orcid.org/0000-0001-8887-8499)
- Wenjie Li (ORCID: https://orcid.org/0000-0001-5285-8939)
Institutions
- Southern Medical University (CN)
Publication Details
- Journal
- Expert Opinion on Drug Safety
- Published
- 2025-04-15
- DOI
- https://doi.org/10.1080/14740338.2025.2494684
- Primary Topic
- Cancer Immunotherapy and Biomarkers
- Type
- article
- Field-Weighted Citation Impact
- 0.00